25
Participants
Start Date
January 14, 2021
Primary Completion Date
September 15, 2022
Study Completion Date
September 15, 2022
Apatinib mesylate tablet
The dose of apatinib mesylate tablets is 250mg, oral, qd, continuous administration, 4 weeks (28 days) as an observation cycle.
PD-1
The dose of PD - 1 is 200 mg/ time, intravenous injection, q2w, 4 weeks (28 days) for an observation period.
Guilin Medical University, Guilin
Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin
People's Hospital of Laibin, Laibin
People's Hospital of Lingshan, Linshan
Wuzhou Red Cross Hospital, Wuzhou
Wuzhou Red Cross Hospital
OTHER
Guangxi Naxishan Hospital
OTHER
Laibin People's Hospital
OTHER
People's Hospital of Lingshan
UNKNOWN
Wei Jiang
OTHER